Background. Although the human papillomavirus (HPV) vaccine has been approved for use in adolescents in the US for over a decade, vaccination uptake remains low. Of concern, HPV vaccine coverage is below the national average in Minnesota, USA. To understand the reach of current HPV programming and research, we use an online media scan; this method may be applied to other jurisdictions to gain insight about various public health issues. Design and Methods. This online media scan describes the nature and scope of ongoing activities to increase HPV vaccination in Minnesota. The media scan included: a) structured internet searches of HPV vaccine health education/promotion activities ongoing in Minnesota since 2013, and b) searches in research databases of the published literature on HPV vaccination in Minnesota from 2013 to 2018. Results. Searches resulted in 880 online and 142 research article matches, with 40 and 36 meeting selection criteria. Results were categorized by activities focusing on race/ethnicity, sex, health providers, parents, lesbian, gay, bisexual, transgender and queer or questioning (LGBTQ) populations, geographic location, catchup vaccination, and insurance status. Most activities were statewide (52% health education/promotion and 35% research), followed by activities located in entirely urban areas (15% health education/promotion and 41% research) with only 6% of health education/promotion activities and 2% of research activities carried out in entirely rural areas. Conclusions. A range of local and statewide HPV vaccine health education/promotion and research activities were identified in Minnesota. Several efforts partnered with American Indian and Somali/Somali-American communities, but fewer activities focused on HPV vaccination among LGBTQ youth and HPV vaccination in rural areas.
Bibliographical noteFunding Information:
Selected Local Area Vaccination Coverage Among Correspondence: Emily A. Groene, Department of Epidemiology and Adolescents Aged 13-17 Years-United States, 2016. MMWR Community Health, University of Minnesota School of Public Health, Morb Mortal Wkly Rep 2017;66: 874-82. 1300 2nd Avenue S, Minneapolis, MN, 55108, USA. 8. National Foundation for Infectious Diseases. Call to Action. Tel.: +1.7632482142. 2014. Available from: http://www.nfid.org/publications/cta E-mail: email@example.com 9. National Conference of State Legislatures. HPV Vaccine: State Key words: media scan, vaccine, disparities, systematic review, human Legislation and Statutes. 2018. Available from: papillomavirus. http://www.ncsl.org/research/health/hpv-vaccine-state-legisla-Acknowledgements: the authors acknowledge Shanda Hunt, Liaison & tion-and-statutes.aspx Data Curation Specialist to the School of Public Health at the University 10. Jacobson RM, Rogacki B, Thompson DM, et al. Vaccination of Minnesota for providing support that contributed to this research. Rates among Adolescents in Minnesota as Compared with the Contributions: EG: Primary author,responsible for drafting and revi- United States Not “Above Average.” Minn Med 2015;38-43. sions according to contributor comments. Carried out searches, 11. MN Community Measurement MD of HS. 2016 Health Care designed classification technique and methods, and checked for concor- Disparities Report for Minnesota Health Care Programs. 2016. dance. IM: Secondary author,carried out searches, checked for concor-Available from: https://mncm.org/wp-dance, revised draft. KH, NEB, NY: Provided feedback on study content/uploads/2017/03/2016-Disparities-Report-Final-design, interpretation and presentation of results. Provided manuscript 2.28.2017.pdf revisions. SK: Senior author,carried out final review and guided strate- 12. Minnesota Department of Health. 2017 Minnesota Statewide gy of paper development. Provided feedback on study design, interpre- Health Assessment. 2017. Available frm: tation and presentation of results. Responsible for final review and https://www.health.state.mn.us/communities/practice/healthy approval for publication. mnpartnership/docs/2017MNStatewideHealthAssessment.pdf Conflict of interest: the authors declare no potential conflict of interest. 13. Esposito S, Principi N, Cornaglia G. Barriers to the vaccina-Funding: the paper is supported by a Healthcare Delivery Research tion of children and adolescents and possible solutions. Clin Program grant from the National Cancer Institute Division of Cancer Microbiol Infect 2014;20:25-31. Control & Population Sciences (NCI 5P30CA077598-19). 14. Minnesota Department of Health. Minnesota Vaccines for Received for publication: 17 May 2019. Children Program (MnVFC). Available from: Revision received: 25 July 2019. http://www.health.state.mn.us/divs/idepc/immunize/mnvfc/ind Accepted for publication: 30 July 2019. ex.html [cited 2018 Aug 6]. ©Copyright: the Author(s), 2019 15. Charlton BM, Reisner SL, Agénor M, et al. Sexual Orientation use only Licensee PAGEPress,Italy Disparities in Human Papillomavirus Vaccination in a Journal of Public Health Research2019;8:1623 Longitudinal Cohort of U.S. Males and Females. LGBT Health doi:10.4081/jphr.2019.1623 2017;4:202-9. This work is licensed under a Creative 16. Beachler DC, Pinto LA, Kemp TJ, et al. An Examination of NonCommercial4.0 License (CC BY-NC4.0). HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study. Cancer Epidemiol Biomarkers Prev 2018;27:496-502. 17. Leeds M, Muscoplat MH. Timeliness of Receipt of Early
- Human papillomavirus
- Media scan
- Systematic review